DE69621521D1 - Cyclodextrinderivate, ihre Herstellung und Verwendung zur Einbringung von hydrophoben Molekülen in strukturierten Tensidsystemen - Google Patents

Cyclodextrinderivate, ihre Herstellung und Verwendung zur Einbringung von hydrophoben Molekülen in strukturierten Tensidsystemen

Info

Publication number
DE69621521D1
DE69621521D1 DE69621521T DE69621521T DE69621521D1 DE 69621521 D1 DE69621521 D1 DE 69621521D1 DE 69621521 T DE69621521 T DE 69621521T DE 69621521 T DE69621521 T DE 69621521T DE 69621521 D1 DE69621521 D1 DE 69621521D1
Authority
DE
Germany
Prior art keywords
introduction
production
cyclodextrin derivatives
surfactant systems
hydrophobic molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69621521T
Other languages
English (en)
Other versions
DE69621521T2 (de
Inventor
Florence Djedaini-Pilard
Jing Lin
Bruno Perly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA filed Critical Commissariat a lEnergie Atomique CEA
Application granted granted Critical
Publication of DE69621521D1 publication Critical patent/DE69621521D1/de
Publication of DE69621521T2 publication Critical patent/DE69621521T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
DE69621521T 1995-06-29 1996-06-27 Cyclodextrinderivate, ihre Herstellung und Verwendung zur Einbringung von hydrophoben Molekülen in strukturierten Tensidsystemen Expired - Fee Related DE69621521T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9507841A FR2736056B1 (fr) 1995-06-29 1995-06-29 Derives de cyclodextrines, leur preparation et leur utilisation pour incorporer des molecules hydrophobes dans des systemes de tensioactifs organises

Publications (2)

Publication Number Publication Date
DE69621521D1 true DE69621521D1 (de) 2002-07-11
DE69621521T2 DE69621521T2 (de) 2003-01-02

Family

ID=9480518

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69621521T Expired - Fee Related DE69621521T2 (de) 1995-06-29 1996-06-27 Cyclodextrinderivate, ihre Herstellung und Verwendung zur Einbringung von hydrophoben Molekülen in strukturierten Tensidsystemen

Country Status (8)

Country Link
US (1) US5821349A (de)
EP (1) EP0751150B1 (de)
JP (1) JPH0912605A (de)
AU (1) AU699482B2 (de)
DE (1) DE69621521T2 (de)
FR (1) FR2736056B1 (de)
HU (1) HUP9601791A3 (de)
ZA (1) ZA965364B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792942B1 (fr) * 1999-04-29 2001-06-08 Commissariat Energie Atomique Cyclodextrines amphiphiles, leur preparation et leur utilisation pour solubiliser des systemes organises et incorporer des molecules hydrophobes
WO2001070697A1 (en) * 2000-03-20 2001-09-27 Teva Pharmaceutical Industries Ltd. Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and n-(4-methoxyphenyl)-3-chloropropionamide
JP2003531930A (ja) * 2000-04-28 2003-10-28 ユニバーシティ・カレッジ・ダブリン 両親媒性大環状誘導体およびそれらの類似体
US6527887B1 (en) 2002-01-18 2003-03-04 Mach I, Inc. Polymeric cyclodextrin nitrate esters
FR2861396B1 (fr) * 2003-10-24 2005-12-16 Commissariat Energie Atomique Derives amphiphiles de cyclodextrines,leur procede de preparation et leurs utilisations
JP2007538112A (ja) * 2004-01-29 2007-12-27 ピナクル ファーマシューティカルズ β−シクロデキストリン誘導体およびそれらの炭疽致死毒に対する使用
MX2007010129A (es) * 2005-01-28 2007-11-16 Pinnacle Pharmaceuticals Inc Derivados de beta-ciclodextrina como agentes antibacteriales.
JP5364923B2 (ja) * 2009-01-28 2013-12-11 学校法人福岡大学 多機能性シクロデキストリン誘導体、その包接化合物およびそれらの製造方法。
PE20151519A1 (es) 2009-03-30 2015-10-28 Eisai Randd Man Co Ltd Composicion de liposoma
US9968583B2 (en) 2009-03-30 2018-05-15 Eisai R & D Management Co., Ltd. Method of manufacture of liposome composition
US11083705B2 (en) 2019-07-26 2021-08-10 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
WO1995015746A1 (en) * 1993-12-10 1995-06-15 The School Of Pharmacy Liposome delivery systems

Also Published As

Publication number Publication date
AU699482B2 (en) 1998-12-03
EP0751150A1 (de) 1997-01-02
HU9601791D0 (en) 1997-06-30
DE69621521T2 (de) 2003-01-02
HUP9601791A2 (en) 1997-05-28
ZA965364B (en) 1997-01-23
HUP9601791A3 (en) 1997-08-28
US5821349A (en) 1998-10-13
FR2736056B1 (fr) 1997-08-08
FR2736056A1 (fr) 1997-01-03
JPH0912605A (ja) 1997-01-14
AU5616496A (en) 1997-01-09
EP0751150B1 (de) 2002-06-05

Similar Documents

Publication Publication Date Title
NO991942D0 (no) FremgangsmÕte for fremstilling av malonat metyliden nanopartikler, nanopartikler eventuelt inneholdende en eller flere biologisk aktive molekyler
DE69724142D1 (de) Sulfonamid-derivate, verfahren zur ihrer herstellung und ihre verwendung als arzneimittel
DE59404480D1 (de) Fullerenderivate, verfahren zur herstellung und deren verwendung
DE69505296T2 (de) Erythromycinderivate, ihre Verfahren zur Herstellung und ihre Verwendung als Arzneimittel
DE69506496T2 (de) Verfahren zur Herstellung von modifizierten Harzen und ihre Verwendungen
DE69627659D1 (de) Neue thrombin-inhibitoren, deren herstellung und verwendung
DE69623992D1 (de) Derivate von dolestatin, deren herstellung und verwendung
DE69712610T2 (de) Erythramicin-derivate, ihre verfahren zur herstellung und ihre verwendung als arzneimittel
DE69711230T2 (de) Biologisch aktive substanzen, verfahren zur herstellung und sie enthaltende zusammensetzungen
DE59711006D1 (de) Emulgatormischungen und deren verwendung zur herstellung von pit-emulsionen
DE69621521D1 (de) Cyclodextrinderivate, ihre Herstellung und Verwendung zur Einbringung von hydrophoben Molekülen in strukturierten Tensidsystemen
BR9607023A (pt) Método para produção de aminoetilenolamina e/ou hidroxietil piperazina
DE69626682D1 (de) Verfahren zur herstellung von guanidinderivaten, zwischenprodukte dafür und ihre herstellung
ATE195937T1 (de) Pyridazinone-derivate und verfahren zur deren herstellung
DE59603431D1 (de) Verfahren zur herstellung von organisch modifizierten aerogelen und deren verwendung
DE69608477T2 (de) Organoaluminoxyprodukt, Katalysatorsystem, deren Herstellung und Verwendung
DE69413183T2 (de) Indazolsulfonylharnstoff-derivat, verwendung und zwischenprodukte zur herstellung
DE59606806D1 (de) Polymerholz-formkörper, ihre herstellung und verwendung
DE69902714T2 (de) Verfahren zur Herstellung von Naturkautschuk und damit erhaltener Naturkautschuk
DE59408857D1 (de) Vorrichtung zur kontinuierlichen Herstellung von Polyacetalen und ihre Verwendung
DE69903880D1 (de) Oxidationskatalysator-System und dessen Verwendung zur Herstellung von Ketoisophoron
DE59500393D1 (de) Verfahren zur Herstellung von Cyclopropylalkylketonen und 4,5-Dihydroalkylfuranen
DE578388T1 (de) Verfahren zur fermentativen Herstellung von 10-Hydroxy-C18-Carbonsäure und Gamma-Dodekalaktonderivaten.
ATE321772T1 (de) Echinocandinderivate, deren herstellung und deren verwendung zur bekämpfung von pilzen
DE69701404D1 (de) Umesterungsverfahren zur Herstellung von Dihydromyrcenol und Myrcenol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee